Literature DB >> 6616468

Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody.

Y Hashimoto, M Sugawara, T Masuko, H Hojo.   

Abstract

Sonicated liposomes containing actinomycin D in the membranes were chemically coated with the subunits of monoclonal immunoglobulin M (IgM) antibody against a mouse mammary tumor-associated antigen (MM antigen) and examined for their in vitro and in vivo antitumor effects against MM46 (MM+) and MM48 (MM-) tumors of C3H/He mouse origin. The antibody-bearing, actinomycin D-containing liposomes (chemoimmunoliposomes) were selectively bound to MM+ tumor cells and showed much more in vitro cytotoxicity against the tumor cells than that shown by free actinomycin D. The in vivo antitumor effect of the chemoimmunoliposomes was tested on the mammary tumor cells (5 X 10(4) to 5 X 10(6) transplanted i.p. into syngeneic mice. A single i.p. injection of the chemoimmunoliposomes containing 0.3, 0.5, or 1 microgram of actinomycin D into MM46 tumor-bearing mice resulted in the cure of some mice and a prolonged survival time in the rest of the mice as compared to results in controls. In this test, free actinomycin D, anti-MM IgM antibody, and bovine serum albumin-coated liposomes containing actinomycin D were marginally effective or ineffective. To examine a systemic antitumor effect of chemoimmunoliposomes, mice were inoculated with MM46 tumor cells and then treated with a single i.v. injection of liposomes 4 days later. If the mice were pretreated with an i.v. injection of unmodified multilamellar liposomes, an injection of the chemoimmunoliposomes containing 1 microgram of actinomycin D resulted in a significant inhibition of tumor growth. Both free actinomycin D and bovine serum albumin-coated liposomes containing actinomycin D were ineffective against the s.c. tumor. These results indicate that an antitumor drug entrapped in the membranes of small sonicated liposomes bearing antitumor monoclonal antibodies can be delivered to antigenic tumor cells and exert more efficient antitumor activity than does the free drug.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616468

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Selective killing of T lymphocytes by phototoxic liposomes.

Authors:  S Yemul; C Berger; A Estabrook; S Suarez; R Edelson; H Bayley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

2.  The antitumor effects of adriamycin entrapped in liposomes on lymph node metastases.

Authors:  H Konno; T Tadakuma; K Kumai; T Takahashi; K Ishibiki; O Abe; S Sakaguchi
Journal:  Jpn J Surg       Date:  1990-07

3.  Potent effects of the monoclonal antibody-mitomycin C conjugate on human colon cancers.

Authors:  H Kotanagi; K Fukuda; N Ogata; M Takahashi; T Masuda; K Koyama; T Takahashi
Journal:  Jpn J Surg       Date:  1987-01

4.  Tumour targeting with antibody-coupled liposomes: failure to achieve accumulation in xenografts and spontaneous liver metastases.

Authors:  S Matzku; H Krempel; H P Weckenmann; V Schirrmacher; H Sinn; H Stricker
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model.

Authors:  H Yanagië; T Tomita; H Kobayashi; Y Fujii; T Takahashi; K Hasumi; H Nariuchi; M Sekiguchi
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

6.  Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy.

Authors:  H Yanagië; T Tomita; H Kobayashi; Y Fujii; Y Nonaka; Y Saegusa; K Hasumi; M Eriguchi; T Kobayashi; K Ono
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  In vitro targeting and cytotoxicity of adriamycin in liposomes bearing monoclonal antibody against rat or human gp125 cell proliferation-associated antigen.

Authors:  T Tanaka; S Suzuki; T Masuko; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1989-04

8.  Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes.

Authors:  I Uyama; K Kumai; T Yasuda; T Tagawa; K Ishibiki; M Kitajima; T Tadakuma
Journal:  Jpn J Cancer Res       Date:  1994-04

9.  Expression of tumor-associated glycoantigen, sialyl Lewis(a), in human head and neck squamous cell carcinoma and its application to tumor immunotherapy.

Authors:  K Makino; T Ogata; H Miyake; S Habu; T Nishimura
Journal:  Jpn J Cancer Res       Date:  1994-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.